Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayesha Appa

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
AIDS and Behavior|April 5, 2022
Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic painJanelle Silvis, Christopher L Rowe, Sarah Dobbins, et al.
Open Forum Infectious Diseases|October 20, 2025
Discontinuation of Long-acting Injectable Cabotegravir-Rilpivirine in a Large Clinic CohortKaterina A Christopoulos, Xavier Erguera, Janet Grochowski, et al.
JMIR Research Protocols|August 18, 2025
Harm Reduction Contingency Management for Stimulant Use Reduction and Antiretroviral Therapy Adherence in HIV Primary Care: Protocol for an Implementation Effectiveness StudyGabriela Steiner, Stefan Baral, Elise D Riley, et al.
The American Journal of Medicine|September 11, 2021
Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive Staphylococcus aureus Infections: Opportunities for ImprovementAyesha Appa, Meredith Adamo, Stephenie Le, et al.
Research Square|February 27, 2026
Mechanisms of overdose from unintentional fentanyl use when intending to use stimulants: a qualitative study of people who use stimulants and avoid opioidsBryson O Gomez, Elyssa Y Samayoa, Phillip O Coffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2026
Integrating HIV and Stimulant Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV CareAyesha Appa, Gabriela Steiner, Stefan Baral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort StudyAyesha Appa, Meredith Adamo, Stephenie Le, et al.
The Journal of Infectious Diseases|June 27, 2022
HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing HomelessnessMatthew D Hickey, Elizabeth Imbert, Ayesha Appa, et al.
Violence Against Women|January 10, 2024
A Qualitative Exploration of Intimate Partner Violence Among HIV/TB Coinfected Persons With Problematic Alcohol Use Participating in an Incentive-Based Alcohol/Medication Adherence Intervention in Uganda During COVID-19Amanda P Miller, Ayesha Appa, Winnie Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2024
Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial ViremiaMatthew D Hickey, Nathanael Gistand, Janet Grochowski, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
AIDS and Behavior|April 5, 2022
Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic painJanelle Silvis, Christopher L Rowe, Sarah Dobbins, et al.
Open Forum Infectious Diseases|October 20, 2025
Discontinuation of Long-acting Injectable Cabotegravir-Rilpivirine in a Large Clinic CohortKaterina A Christopoulos, Xavier Erguera, Janet Grochowski, et al.
JMIR Research Protocols|August 18, 2025
Harm Reduction Contingency Management for Stimulant Use Reduction and Antiretroviral Therapy Adherence in HIV Primary Care: Protocol for an Implementation Effectiveness StudyGabriela Steiner, Stefan Baral, Elise D Riley, et al.
The American Journal of Medicine|September 11, 2021
Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive Staphylococcus aureus Infections: Opportunities for ImprovementAyesha Appa, Meredith Adamo, Stephenie Le, et al.
Research Square|February 27, 2026
Mechanisms of overdose from unintentional fentanyl use when intending to use stimulants: a qualitative study of people who use stimulants and avoid opioidsBryson O Gomez, Elyssa Y Samayoa, Phillip O Coffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2026
Integrating HIV and Stimulant Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV CareAyesha Appa, Gabriela Steiner, Stefan Baral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort StudyAyesha Appa, Meredith Adamo, Stephenie Le, et al.
The Journal of Infectious Diseases|June 27, 2022
HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing HomelessnessMatthew D Hickey, Elizabeth Imbert, Ayesha Appa, et al.
Violence Against Women|January 10, 2024
A Qualitative Exploration of Intimate Partner Violence Among HIV/TB Coinfected Persons With Problematic Alcohol Use Participating in an Incentive-Based Alcohol/Medication Adherence Intervention in Uganda During COVID-19Amanda P Miller, Ayesha Appa, Winnie Muyindike, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2024
Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial ViremiaMatthew D Hickey, Nathanael Gistand, Janet Grochowski, et al.
Pageof 3